Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Dhiraj Abhyankar"'
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Immuno-oncology drugs (IODs) have revolutionized the treatment of some cancers. Although IODs are enabling some patients with cancer to become long-time survivors, only 30% to 40% respond to these drugs. There is experimental and clinical evidence th
Externí odkaz:
https://doaj.org/article/1819c919d409430b96370f6412ec297a
Autor:
Dhiraj Abhyankar
Publikováno v:
South Asian Journal of Cancer, Vol 7, Iss 3, Pp 193-194 (2018)
Externí odkaz:
https://doaj.org/article/161589d7cfdf4fdf97a304767c4ee792
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights. Oncology
Immuno-oncology drugs (IODs) have revolutionized the treatment of some cancers. Although IODs are enabling some patients with cancer to become long-time survivors, only 30% to 40% respond to these drugs. There is experimental and clinical evidence th
Supplemental material, Permission_doc_1 for Gut Microbiota and Response to Immunotherapeutic Drugs in Oncology: More Questions Than Answers by Dhiraj Abhyankar, Kelly T McKee and Pavle Vukojevic in Clinical Medicine Insights: Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cedbbdf3aedce6d6a7c4087db6bbddb
Publikováno v:
Therapeutic Delivery. 7:545-551
Background: Cyclizine is used in the treatment and prevention of nausea and vomiting. We aimed to demonstrate bioequivalence between two formulations of cyclizine 50 mg tablets. Methods/Results: This single-dose, two-treatment, two-period, two-sequen
Publikováno v:
International Journal of STD & AIDS. 28:491-498
The objective of this study was to assess the bioequivalence between a fixed-dose combination of tenofovir disoproxil fumarate/lamivudine/efavirenz 300/300/600 mg and the individual innovator products. A randomized, balanced, open-label, two-sequence
Autor:
Dhiraj Abhyankar, Anita Iyer, Subramanian Krishnakumar, Vaijayanthi Pusphparaj, Jyotirmay Biswas, Sundaram Amirtha Lakshmi
Publikováno v:
Cornea. 24:337-341
PURPOSE Malignant transformation of cells is frequently associated with abnormalities in HLA expression. These abnormalities may play a significant role in the clinical course of the disease because the cellular immune response to tumors relies on co
Autor:
Subramanian Krishnakumar, Tarun Sharma, Mahesh P Shanmugam, Vanitha Krishnamurthy, Jyotirmay Biswas, Lingam Gopal, Amirthalakshmi Sundaram, Dhiraj Abhyankar
Publikováno v:
Cancer. 100:1059-1069
BACKGROUND Malignant transformation of cells is frequently associated with abnormalities in human leukocyte antigen (HLA) expression. These abnormalities may play a role in the clinical course of the disease, because HLAs mediate interactions of tumo
Autor:
Dhiraj Abhyankar, Subramanian Krishnakumar, Sundaram Amirtha Lakshmi, Mahesh P Shanmugam, Jyotirmay Biswas, Vaijayanthi Pushparaj
Publikováno v:
Experimental Eye Research. 77:175-180
The authors examined the immunoexpression of human leukocyte (HLA) class II antigen in uveal melanomas and correlated with the cell types, largest tumour dimension and extrascleral invasion. HLA class II antigen expression was analysed in 45 primary
Publikováno v:
Orbit. 22:265-270
To study the antigen-processing molecules in primary orbital melanomas and correlate them with the clinicopathological features.Antigen-processing molecules comprising the low molecular weight proteins LMP2 and LMP10, transporter associated with anti